🇺🇸 FDA
Patent

US 7935693

Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

granted A61KA61K31/4196A61K31/4375

Quick answer

US patent 7935693 (Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
63
CPC classes
A61K, A61K31/4196, A61K31/4375, A61K31/4439, A61P